Herndon, Virginia (PressExposure) September 07, 2011 -- Trianz Solutions, a global technology provider of innovative solutions is pleased to announce its participation in SCDM 2011 - a premier event for the life science industry, to be held in Baltimore Sep 11th to 14th. The 4-day conference will provide a platform for the life sciences organization to learn about the new trends and technologies in the industry and capitalize on these rapid changes.
Trianz Solutions, a platinum sponsor of the event, will unveil Acceliant 6.4v, a comprehensive eClinical data management solution, designed to support end to end clinical trial life cycle. Acceliant 6.4v offers its clients the advantage of having integrated access to ePRO data within the EDC platform. This Integrated Access will eliminate the need for multiple web portals and increase the usability of the data. The new upgraded version exhibits features which include:
Supports Phase I-IV Trials & post marketing studies
Learning Management System (LMS)
Patient Focused Portal
Automated Dictionary Coding of captured Clinical Data
Easy Navigation between Modules
Key highlights at the event - Demo of Acceliant 6.4V on Sept 12th 2011 from 7:30-8:30am. A full lineup demonstration on Integrated ePRO and EDC will be exhibited which will include Learning Management System (LMS) and Multilingual Support as well. Please visit http://www.trianzsolutions.com/register-demo-scdm-2011.php to register for the demo.
Speaking about the participation, Ven Thangaraj, Head of Acceliant said, "SCDM 2011 creates a next-generation clinical technology platform to understand the administrative and technical challenges and solutions. Participating in SCDM event moves Trianz solutions closer to fulfill and incorporate customer's needs. Acceliant has been developed and will evolve as per the changing requirements of clients and industry standards."
To know more about the solutions and offerings, meet us at our booth (booth no: 208 & 210) during the event and find out more about the unique features of Acceliant's 6.4V which make it dominant and coveted in the entire range of electronic Clinical Trial Suite.